|
|
| | Rulonilimab Basic information |
| Product Name: | Rulonilimab | | Synonyms: | Rulonilimab;Research Grade Rulonilimab (DHH02231);Research Grade Rulonilimab;Rulonilimab (anti-PDCD1) | | CAS: | 2417124-95-7 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Rulonilimab Structure]() |
| | Rulonilimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Rulonilimab Usage And Synthesis |
| Uses | Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity[1]. | | References | [1] Phase Ⅱ/III Studies to Investigate the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib Compared to Placebo in Combination With Lenvatinib as First-Line Therapy in Subjects With Hepatocellular Carcinoma (HCC). |
| | Rulonilimab Preparation Products And Raw materials |
|